These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 18031230

  • 1. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
    Shih HM, Chang CC, Kuo HY, Lin DY.
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
    [Abstract] [Full Text] [Related]

  • 2. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, Chao TT, Ho CC, Chen YC, Lin TP, Fang HI, Hung CC, Suen CS, Hwang MJ, Chang KS, Maul GG, Shih HM.
    Mol Cell; 2006 Nov 03; 24(3):341-54. PubMed ID: 17081986
    [Abstract] [Full Text] [Related]

  • 3. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
    Chen A, Wang PY, Yang YC, Huang YH, Yeh JJ, Chou YH, Cheng JT, Hong YR, Li SS.
    J Cell Biochem; 2006 Jul 01; 98(4):895-911. PubMed ID: 16475184
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of the dual-function transcription factor Sp3 by SUMO.
    Valin A, Gill G.
    Biochem Soc Trans; 2007 Dec 01; 35(Pt 6):1393-6. PubMed ID: 18031229
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Physical and functional interactions between Daxx and TSG101.
    Muromoto R, Sugiyama K, Yamamoto T, Oritani K, Shimoda K, Matsuda T.
    Biochem Biophys Res Commun; 2004 Apr 09; 316(3):827-33. PubMed ID: 15033475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML.
    Weisshaar SR, Keusekotten K, Krause A, Horst C, Springer HM, Göttsche K, Dohmen RJ, Praefcke GJ.
    FEBS Lett; 2008 Sep 22; 582(21-22):3174-8. PubMed ID: 18708055
    [Abstract] [Full Text] [Related]

  • 12. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
    Müncheberg S, Hay RT, Ip WH, Meyer T, Weiß C, Brenke J, Masser S, Hadian K, Dobner T, Schreiner S.
    J Virol; 2018 Jul 01; 92(13):. PubMed ID: 29695423
    [Abstract] [Full Text] [Related]

  • 13. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.
    Li Q, Wang X, Wu X, Rui Y, Liu W, Wang J, Wang X, Liou YC, Ye Z, Lin SC.
    Cancer Res; 2007 Jan 01; 67(1):66-74. PubMed ID: 17210684
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential.
    Huang YS, Shih HM.
    Biochem Biophys Res Commun; 2009 Sep 04; 386(4):762-8. PubMed ID: 19563778
    [Abstract] [Full Text] [Related]

  • 17. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.
    Jacobs AM, Nicol SM, Hislop RG, Jaffray EG, Hay RT, Fuller-Pace FV.
    Oncogene; 2007 Aug 30; 26(40):5866-76. PubMed ID: 17369852
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of NF-kappaB acetylation and its transcriptional activity by Daxx.
    Park J, Lee JH, La M, Jang MJ, Chae GW, Kim SB, Tak H, Jung Y, Byun B, Ahn JK, Joe CO.
    J Mol Biol; 2007 Apr 27; 368(2):388-97. PubMed ID: 17362989
    [Abstract] [Full Text] [Related]

  • 19. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F, Müller S, Pandolfi PP, Dejean A.
    Oncogene; 2001 Jan 04; 20(1):1-9. PubMed ID: 11244500
    [Abstract] [Full Text] [Related]

  • 20. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin.
    Chalkiadaki A, Talianidis I.
    Mol Cell Biol; 2005 Jun 04; 25(12):5095-105. PubMed ID: 15923626
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.